Literature DB >> 26763675

Generalised anxiety disorder in children and adolescents.

Christopher K Gale1, Jane Millichamp.   

Abstract

INTRODUCTION: Generalised anxiety disorder (GAD) in a child or adolescent is excessive worry and tension about everyday events that the child or adolescent cannot control and that is expressed on most days for at least 6 months, to the extent that there is distress or difficulty in performing day-to-day tasks. METHODS AND OUTCOMES: We conducted a systematic overview, aiming to answer the following clinical question: What are the effects of pharmacological treatments for generalised anxiety disorder in children and adolescents? We searched: Medline, Embase, The Cochrane Library, and other important databases up to August 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review).
RESULTS: At this update, searching of electronic databases retrieved 949 studies. After deduplication and removal of conference abstracts, 417 records were screened for inclusion in the overview. Appraisal of titles and abstracts led to the exclusion of 310 studies and the further review of 107 full publications. Of the 107 full articles evaluated, one systematic review was added at this update. We performed a GRADE evaluation for six PICO combinations.
CONCLUSIONS: In this systematic overview, we categorised the efficacy for six interventions based on information about the effectiveness and safety of antidepressants, antipsychotics, benzodiazepines, buspirone, hydroxyzine, and pregabalin.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26763675      PMCID: PMC4711893     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  15 in total

1.  24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).

Authors:  John Piacentini; Shannon Bennett; Scott N Compton; Phillip C Kendall; Boris Birmaher; Anne Marie Albano; John March; Joel Sherrill; Dara Sakolsky; Golda Ginsburg; Moira Rynn; R Lindsey Bergman; Elizabeth Gosch; Bruce Waslick; Satish Iyengar; James McCracken; John Walkup
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-28       Impact factor: 8.829

2.  Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.

Authors:  M A Rynn; L Siqueland; K Rickels
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

3.  Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristics.

Authors:  M Burstein; K Beesdo-Baum; J-P He; K R Merikangas
Journal:  Psychol Med       Date:  2014-01-02       Impact factor: 7.723

4.  Somatic symptoms in children and adolescents with anxiety disorders.

Authors:  Golda S Ginsburg; Mark A Riddle; Mark Davies
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-10       Impact factor: 8.829

5.  Fluoxetine for the treatment of childhood anxiety disorders.

Authors:  Boris Birmaher; David A Axelson; Kelly Monk; Catherine Kalas; Duncan B Clark; Mary Ehmann; Jeffery Bridge; Jungeun Heo; David A Brent
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-04       Impact factor: 8.829

6.  Generalized anxiety disorder in a nonclinical sample of children: symptom presentation and predictors of impairment.

Authors:  Ann E Layne; Debra H Bernat; Andrea M Victor; Gail A Bernstein
Journal:  J Anxiety Disord       Date:  2008-08-12

7.  Are children with "pure" generalized anxiety disorder impaired? A comparison with comorbid and healthy children.

Authors:  Candice A Alfano
Journal:  J Clin Child Adolesc Psychol       Date:  2012-09-10

8.  Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders.

Authors:  J G Simeon; H B Ferguson; V Knott; N Roberts; B Gauthier; C Dubois; D Wiggins
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-01       Impact factor: 8.829

9.  Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.

Authors:  John T Walkup; Anne Marie Albano; John Piacentini; Boris Birmaher; Scott N Compton; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James McCracken; Bruce Waslick; Satish Iyengar; John S March; Philip C Kendall
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

10.  Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Authors:  Jeffrey A Bridge; Satish Iyengar; Cheryl B Salary; Rémy P Barbe; Boris Birmaher; Harold Alan Pincus; Lulu Ren; David A Brent
Journal:  JAMA       Date:  2007-04-18       Impact factor: 56.272

View more
  5 in total

1.  Anxiety among Adolescents and Young Adults during COVID-19 Pandemic: A Multi-Country Survey.

Authors:  Heba Jafar Sabbagh; Wafaa Abdelaziz; Waleed Alghamdi; Maryam Quritum; Nada AbuBakr AlKhateeb; Joud Abourdan; Nafeesa Qureshi; Shabnum Qureshi; Ahmed H N Hamoud; Nada Mahmoud; Ruba Odeh; Nuraldeen Maher Al-Khanati; Rawiah Jaber; Abdulrahman Loaie Balkhoyor; Mohammed Shabi; Morenike Oluwatoyin Folayan; Omolola Alade; Noha Gomaa; Raqiya Alnahdi; Nawal A Mahmoud; Hanane El Wazziki; Manal Alnaas; Bahia Samodien; Rawa A Mahmoud; Nour Abu Assab; Sherin Saad; Sondos G Alhachim; Maha El Tantawi
Journal:  Int J Environ Res Public Health       Date:  2022-08-24       Impact factor: 4.614

2.  Longitudinal association between parental-to-child-Maltreatment and self-reported Generalized Anxiety Disorder symptoms in Pakistani Adolescents.

Authors:  Maryam Pyar Ali Lakhdir; Ghazal Peerwani; Salman Muhammad Soomar; Apsara Ali Nathwani; Salima Farooq; Naureen Akber Ali; Asif Khaliq; Muhammad Masood Kadir; Syed Iqbal Azam
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2021-07-14       Impact factor: 3.033

3.  Anxiety related disorders in adolescents in the United Arab Emirates: a population based cross-sectional study.

Authors:  Nabeel Al-Yateem; Wegdan Bani Issa; Rachel C Rossiter; Arwa Al-Shujairi; Hadia Radwan; Manal Awad; Randa Fakhry; Ibrahim Mahmoud
Journal:  BMC Pediatr       Date:  2020-05-25       Impact factor: 2.125

Review 4.  Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine.

Authors:  Dan J Stein
Journal:  Adv Ther       Date:  2021-08-21       Impact factor: 3.845

5.  Toward Linguistic Recognition of Generalized Anxiety Disorder.

Authors:  Laurens Rook; Maria Chiara Mazza; Iulia Lefter; Frances Brazier
Journal:  Front Digit Health       Date:  2022-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.